Improving Outcomes in Major Depressive Disorder– Quantify the impact of major depressive disorder (MDD) and treatment-resistant depression (TRD) on healthcare resource use and patient outcomes. Outline the benefits and limitations of available antidepressant medications and the factors involved in second- and third-line therapy decision making. Describe the utility of depression-related HEDIS measures on plan performance and patient adherence. Develop strategies that aim to lower overall medical costs and improve outcomes in covered patients with MDD and TRD.
1.0 Free AMA Pra CAT 1 CME for Physicians